|
Volumn 30, Issue 17, 2012, Pages 2036-2038
|
Under-representation of older adults in cancer registration trials: Known problem, little progress
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENDAMUSTINE;
BEVACIZUMAB;
BORTEZOMIB;
CABAZITAXEL;
CAPECITABINE;
CARBOPLATIN;
CETUXIMAB;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DEGARELIX;
DENILEUKIN DIFTITOX;
ELTROMBOPAG;
ERLOTINIB;
EVEROLIMUS;
FLUDARABINE;
FLUOROURACIL;
GEMCITABINE;
IMATINIB;
INTERFERON;
IXABEPILONE;
LAPATINIB;
LETROZOLE;
NILOTINIB;
OFATUMUMAB;
PACLITAXEL;
PAZOPANIB;
PEMETREXED;
PLERIXAFOR;
PRALATREXATE;
PREDNISONE;
RITUXIMAB;
ROMIDEPSIN;
ROMIPLOSTIM;
SORAFENIB;
TEMSIROLIMUS;
UNINDEXED DRUG;
BREAST METASTASIS;
CANCER PATIENT;
CANCER REGISTRY;
CHRONIC LYMPHATIC LEUKEMIA;
CHRONIC MYELOID LEUKEMIA;
COLON CANCER;
COMORBIDITY;
CUTANEOUS T CELL LYMPHOMA;
DRUG APPROVAL;
ELDERLY CARE;
FOLLICULAR LYMPHOMA;
GASTROINTESTINAL STROMAL TUMOR;
GLIOBLASTOMA;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
KIDNEY CANCER;
KIDNEY CARCINOMA;
KNOWLEDGE;
LARGE CELL LYMPHOMA;
LIVER CELL CARCINOMA;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
MULTIPLE MYELOMA;
NONHODGKIN LYMPHOMA;
NOTE;
PANCREAS CANCER;
PERIPHERAL T CELL LYMPHOMA;
PRIORITY JOURNAL;
PROSTATE CANCER;
RISK BENEFIT ANALYSIS;
SOCIAL SUPPORT;
UNITED STATES;
AGED;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
GERIATRICS;
HUMANS;
MEDICAL ONCOLOGY;
NEOPLASMS;
PATIENT PARTICIPATION;
PATIENT SELECTION;
SEER PROGRAM;
UNITED STATES;
|
EID: 84863889174
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2012.41.6727 Document Type: Note |
Times cited : (327)
|
References (5)
|